With our aging population, Macular Degeneration (MD) and vision loss is becoming a significant contributor to the rise in medical costs for Medicare.
Monitoring companies like ALIM and CUBT (very early play) that have promising therapies for MD. These stocks will move when clinical trials start and/or clinical results that are promising are announced.
JMO
Successful Trading is the art of minimizing long term risk and maximizing capital allocation.